Venostent is a medical device company focused on improving the standard of care for patients with chronic venous insufficiency (CVI). The company has developed a minimally invasive device designed to restore venous function and reduce the symptoms associated with CVI.

VenoStent is a venture backed, clinical stage medical device and tissue engineering company developing bioabsorbable wraps to transform outcomes in vascular surgery

U.S. Department of Health & Human Services

Y Combinator

Olima Ventures

IAG Capital Partners

Kube VC

C3 Ventures

Cowtown Angels

SP Investment Fund

Texas HALO Fund

Creative Ventures

Adam Morley

VenoStent, Inc.

Venostent

COM:VENOSTENT

Venostent

Analysis Not Available